Active Pharmaceutical Ingredient (API)

Benfotiamine

Benfotiamine

Benfotiamine

CAS No 22457-89-2
Theraputic use Dietary supplement to treat Diabetic neuropathy
Status Developed

Eslicarbazepine Acetate

Eslicarbazepine Acetate

Eslicarbazepine Acetate

CAS No 236395-14-5
Theraputic use Anticonvulsant, Anti-epileptic
Status Developed

Levetiracetam

Levetiracetam

Levetiracetam

CAS No 102767-28-2
Theraputic use Anti-epileptic
Status Developed

Teneligliptin Hydrobromide Hydrate

Teneligliptin Hydrobromide Hydrate

Teneligliptin Hydrobromide Hydrate

CAS No 1572583-29-9
Theraputic use Anti-Diabetic (Type-2 ), DPP4 Inhibitor
Status Developed

Vildagliptin

Vildagliptin

Vildagliptin

CAS No 274901-16-5
Theraputic use Anti-lipemic
Status Developed

Deferasirox

Deferasirox

Deferasirox

CAS No 201530-41-8
Theraputic use Treat iron overload caused by blood transfusions
Status Developed

Rosuvastatin Calcium

Rosuvastatin Calcium

Rosuvastatin Calcium

CAS No 274901-16-5
Theraputic use Anti-lipemic
Status Developed